Literature DB >> 22652430

The genetic deletion of Mas abolishes salt induced hypertension in mice.

Silvia Heringer-Walther1, Florian Gembardt, Frank Holger Perschel, Norbert Katz, Heinz-Peter Schultheiss, Thomas Walther.   

Abstract

The G protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor and is associated with angiotensin-(1-7) signaling. We investigated the effect of Mas-deficiency on blood pressure regulation under physiological conditions and salt load using radiotelemetry. Mas-knockout mice and their wild-type controls received a telemetry implant in the carotid artery. One week after surgery, animals were monitored for 3 days receiving normal diet (0.6% NaCl) followed by one-week high-salt diet (8% NaCl). Under same high-salt diet, another set of mice was placed in individual metabolic cages for 4 days. Basal mean arterial pressure, heart rate and locomotor activity displayed normal day-night rhythm in Mas-deficient mice. Mas-knockout mice were normotensive. High dietary NaCl ingestion did not alter heart rate or locomotor activity in both groups, but significantly increased night time mean arterial pressure in control mice whereas this increase was blunted in Mas-deficient mice. Baseline food and water intake and urine osmolality were not different between both genotypes. Under high-salt diet, water consumption and food intake were equally increased in wild-type controls and Mas-knockout, but urinary electrolytes and osmolality were significantly higher in Mas-knockout. Taken together, basal hemodynamic parameters are unchanged in Mas-knockout mice. In contrast to wild-type controls, telemetric mean arterial pressure measurement revealed salt resistance in Mas-deficient animals, probably due to their higher urinary NaCl excretion. This is the first direct proof that Mas blockade might be a new option in the treatment of salt-sensitive hypertension.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22652430     DOI: 10.1016/j.ejphar.2012.05.025

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 2.  The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.

Authors:  Xiao C Li; Jianfeng Zhang; Jia L Zhuo
Journal:  Pharmacol Res       Date:  2017-06-12       Impact factor: 7.658

3.  MAS1 Receptor Trafficking Involves ERK1/2 Activation Through a β-Arrestin2-Dependent Pathway.

Authors:  Flavia M Cerniello; Oscar A Carretero; Nadia A Longo Carbajosa; Bruno D Cerrato; Robson A Santos; Hernán E Grecco; Mariela M Gironacci
Journal:  Hypertension       Date:  2017-09-05       Impact factor: 10.190

4.  Blood pressure, heart rate and tubuloglomerular feedback in A1AR-deficient mice with different genetic backgrounds.

Authors:  S M Kim; D Mizel; Y Qin; Y Huang; J Schnermann
Journal:  Acta Physiol (Oxf)       Date:  2014-09-24       Impact factor: 6.311

5.  The antiobese effect of AT1 receptor blockade is augmented in mice lacking Mas.

Authors:  Carla Dapper; Franziska Schuster; Ines Stölting; Florian Vogt; Lucas Araújo Castro E Souza; Natalia Alenina; Michael Bader; Walter Raasch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-03-13       Impact factor: 3.000

Review 6.  Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting.

Authors:  Hui Lin; Frank Geurts; Luise Hassler; Daniel Batlle; Katrina M Mirabito Colafella; Kate M Denton; Jia L Zhuo; Xiao C Li; Nirupama Ramkumar; Masahiro Koizumi; Taiji Matsusaka; Akira Nishiyama; Martin J Hoogduijn; Ewout J Hoorn; A H Jan Danser
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

7.  Angiotensin-(1-7) abolishes AGE-induced cellular hypertrophy and myofibroblast transformation via inhibition of ERK1/2.

Authors:  Ebaa M Alzayadneh; Mark C Chappell
Journal:  Cell Signal       Date:  2014-09-19       Impact factor: 4.315

8.  Atypical signaling and functional desensitization response of MAS receptor to peptide ligands.

Authors:  Kalyan C Tirupula; Russell Desnoyer; Robert C Speth; Sadashiva S Karnik
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

9.  Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats.

Authors:  Jan Klimas; Michael Olvedy; Katarina Ochodnicka-Mackovicova; Peter Kruzliak; Sona Cacanyiova; Frantisek Kristek; Peter Krenek; Peter Ochodnicky
Journal:  J Cell Mol Med       Date:  2015-03-12       Impact factor: 5.310

Review 10.  New frontiers in the intrarenal Renin-Angiotensin system: a critical review of classical and new paradigms.

Authors:  Jia L Zhuo; Fernanda M Ferrao; Yun Zheng; Xiao C Li
Journal:  Front Endocrinol (Lausanne)       Date:  2013-11-11       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.